GlassScriptPhysician profile
Benigno F Decena
NPI 1023011269
$9,043.90
in general payments reported to CMS, 2019-2025
29 companies · $2,857 in 2025
The $2,857 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $448 · 2020: $704 · 2021: $513 · 2022: $755 · 2023: $1,046 · 2024: $2,721 · 2025: $2,857.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,555 · Travel and Lodging: $3,070.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,554.87 |
| Travel and Lodging | $3,069.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,734.91 | 2019-2025 | Aveir, Tendril, Assurity |
| Boston Scientific Corporation | $2,570.72 | 2019-2025 | Ingevity+, Latitude Communicator Power Supply, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $1,308.17 | 2021-2025 | Pulseselect, Na |
| Novartis Pharmaceuticals Corporation | $654.44 | 2023-2025 | |
| Cvrx, INC. | $299.61 | 2020-2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $225.78 | 2019-2025 | Lifevest |
| Pfizer INC. | $184.53 | 2022-2025 | |
| Kestra Medical Technology Services, INC. | $149.74 | 2024-2025 | Assure Wcd |
| Biotronik INC. | $96.47 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $91.32 | 2019-2020 | |
| Cardiofocus, INC. | $81.22 | 2023-2024 | Heartlight System |
| Biosense Webster, INC. | $78.90 | 2019-2025 | Carto 3 |
| Merck Sharp & Dohme LLC | $58.19 | 2022-2023 | Verquvo |
| Bardy Diagnostics, INC. | $55.00 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $52.97 | 2024 | Arcalyst |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $49.74 | 2021-2024 | Eliquis |
| Sanofi-Aventis U.S. LLC | $46.56 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $41.06 | 2022-2023 | Opsumit, Uptravi |
| Amgen INC. | $37.13 | 2023-2024 | Repatha |
| Edwards Lifesciences Corporation | $32.96 | 2022 | |
| Impulse Dynamics (USA) INC. | $31.72 | 2021-2024 | Optimizer |
| Grifols USA, LLC | $30.93 | 2019 | |
| Shockwave Medical, INC | $26.21 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.95 | 2019-2020 | |
| Terumo Medical Corporation | $19.49 | 2023 | Tr Band |
| Philips North America LLC | $17.44 | 2023 | |
| Kiniksa Pharmaceuticals, LTD. | $17.42 | 2023 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $12.85 | 2019 | |
| Astellas Pharma US INC | $12.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benigno Decena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.